Hepatitis B Vaccine Articles
Dynavax shares leap as US FDA lifts clinical hold on Heplisav
11 September 2009
Dynavax presents further Ph III Heplisav data
30 April 2009
FDA calls for more info on Dynavax' Heplisav
16 February 2009
Dynavax drops 18.8% as Merck & Co ends accord
12 January 2009
ViRexx presents encouraging early data on HBV vacc
1 September 2008
Big immune response with nasal HBV vacc
1 September 2008
Clinical hold on Heplisav by FDA
31 March 2008
Emergent to proceed with HBV vaccine study
14 January 2008
Merck & Co recalls certain lots of Pedvaxhib and Comvax
17 December 2007
Akorn and India's Serum Inst sign US vacc deal
5 November 2007
Headlines 25 years ago this week....
20 November 2006
Dynavax secures $30M equity injection
11 September 2006
Innogenetics' HCV tech granted US/EU patents
19 June 2006
Sanofi Pasteur opens Argentinian hep B plant
12 December 2005
Epimmune's 1st-qtr 2005 net loss rockets
30 May 2005
Corixa and Lorantis sign hep B vacc deal
14 March 2005
Judgement on Hep A vaccination
6 October 2003
Stock Commentary - Europe
22 September 2003
Growing Chinese vaccines market
21 April 2003
Argentine Rx prices fall as generics law bites
17 March 2003
Coley's CpG 7909 boosts hep B vaccine
24 February 2003
Berna Biotech, Samsung plan vaccine plants in Vietnam
10 February 2003
Wockhardt acquires all Rhein Biotech JV
11 September 2001
Govt blamed for India's biotech probs
9 January 2001
Shantha in JV with ABL Technologies
23 October 2000
Chinese nationwide drug inspections
14 September 2000
Celltech recommended by Goldman Sachs
28 March 2000
Drug majors donate $150 mill-plus vaccines
8 March 2000
Vietnam plan to boost vaccines output
20 January 2000
Medeva terminates takeover talks, claims proposal was "opportunistic"
20 September 1999
Cuban hep B vaccine production
15 September 1999
Medeva shares jump on merger talks
9 September 1999
Stock Commentary Europe
19 August 1999
WHO views thiomersal in vaccines
26 July 1999
Medeva sees light at the end of the tunnel
25 May 1999
Phase I trial for CpG
29 April 1999
Setback for Medeva as FDA seeks more data on Hepagene
13 April 1999
Medeva confident about its future
12 February 1999
Rhone-Poulenc reports strong earnings growth
28 January 1999
Medeva Has Heavy Reliance On Hepagene
4 December 1998
Competition Worries Hit Medeva Shares
2 December 1998
Medeva Files For European Approval Of Hepagene
27 October 1998
SmithKline Beecham Expanding In Romania
29 September 1998
Cadila And Korea Green Cross Collaborate
3 September 1998
Isis Grant DNA License to CpG ImmunoPharm
19 August 1998
New Indication For SB's Engerix-B
19 August 1998
Currency And Flu Factors Hold Back SB Results
22 July 1998
J&J Takeover Of Amgen, Rumor Or Reality?
30 June 1998
SB Defends Independence On Strong R&D Grounds
23 April 1998
Pramipexole Approved In The European Union
5 March 1998
PowderJect Signs $300M Deal With Glaxo Wellcome
5 March 1998
GW-SB Merger Will Create R&D Superpower
5 February 1998
Turkey: Cuban Hepatitis B Vaccine
15 January 1998
European And London Stock Comment
23 October 1997
Medeva's Hep B Vaccine; Protective And Therapeutic?
16 October 1997
PowderJect - Boeh Mannheim In $15 Million Collaboration
11 September 1997
Strong Sterling Impacts SmithKline Beecham
23 July 1997
Medeva's Growth Dulled By "Fen-Phen" Effect
17 July 1997
SmithKline Beecham Appointment
17 July 1997
Short-Term Difficulties For Medeva?
8 April 1997
Medeva In IP Transfer Deal With Peptide Therapeutics
3 February 1997
1st Launch Of Merck's Comvax
27 January 1997
Medeva Takes On Single Isomer Methylphenidate
27 January 1997
Gene Delivery Joint Venture Formed
16 December 1996
US Approval To Market Merck & Co's Comvax
14 October 1996
US Clearance For Biogen's Avonex Expected Soon
18 March 1996
SB Trading Profit Up 19% On New Prods
26 February 1996
SB Launches Junior Hep B Vaccine
12 February 1996
Medeva And Janssen In Vaccine Agreement
8 January 1996
European Stock Comment
8 January 1996
SB Chief Argues Patents Are Vital To New Cures
25 September 1995
Iran Pharma Links, Higher spending
3 July 1995
1994 Brings Israel's BTG Closer To Goals
3 July 1995
Biogen Wins Vaccine Dispute With SB
24 April 1995
"Strong Underlying Growth" At SB In 1st Qtr
24 April 1995
Vaccine News From ECCMID
3 April 1995
Filing For Supplement To Albuterol ANDA
20 March 1995
Excellent Results For Medeva In 1994
20 March 1995
Medeva Reports On Hepagene Results
6 March 1995
Biogen Revises 1994 Financial Results
20 February 1995
SB's Carvedilol Effective In Congestive Heart Failure
13 February 1995
Engerix Launch In France
2 January 1995
Highlights Of SmithKline's R&D Portfolio
2 January 1995
Biogen Comes Back Into Europe
19 December 1994
Merieux Negotiates Three Biotech Accords In USA
21 November 1994
Medeva Wins UK Hep B Vaccine Appeal
7 November 1994
EUROPEAN STOCK COMMENT
7 November 1994
SB's Engerix B For Portuguese Program
10 October 1994
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
